Improvements in Intractable Lumbar and LowerExtremity Symptoms after Systemic Administration of Tocilizumab, an Anti-interleukin-6 Receptor Antibody.
Sainoh T, Orita S, Miyagi M, Suzuki-Narita M, Sakuma Y, Oikawa Y, Kubota G, Sato J, Shiga Y, Fujimoto K, Eguchi Y, Koda M, Aoki Y, Akazawa T, Furuya T, Nakamura J, Takahashi H, Maki S, Inoue M, Kinoshita H, Norimoto M, Sato T, Sato M, Suzuki M, Enomoto K, Takaoka H, Mizuki N, Hozumi T, Tsuchiya R, Kim G, Otagiri T, Mukaihata T, Hishiya T, Ohtori S, Inage K.
Sainoh T, et al. Among authors: norimoto m.
Asian Spine J. 2022 Feb;16(1):99-106. doi: 10.31616/asj.2020.0283. Epub 2021 May 21.
Asian Spine J. 2022.
PMID: 34015207
Free PMC article.